Differential roles of RET isoforms in medullary and papillary thyroid carcinomas
- 1 January 2017
- journal article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 24 (1) , 53-69
Abstract
The RET receptor tyrosine kinase mediates cell proliferation, survival and migration in embryogenesis and is implicated in the transformation and tumour progression in multiple cancers. RET is frequently mutated and constitutively activated in familial and sporadic thyroid carcinomas. As a result of alternative splicing, RET is expressed as two protein isoforms, RET9 and RET51, which differ in their unique C-terminal amino acids. These isoforms have distinct intracellular trafficking and associated signalling complexes, but functional differences are not well defined. We used shRNA-mediated knockdown (KD) of individual RET isoforms or of total RET to evaluate their functional contributions in thyroid carcinoma cells. We showed that RET is required for cell survival in medullary (MTC) but not papillary thyroid carcinoma (PTC) cells. In PTC cells, RET depletion reduced cell migration and induced a flattened epithelial-like morphology. RET KD decreased the expression of mesenchymal markers and matrix metalloproteinases and reduced anoikis resistance and invasive potential. Further, we showed that RET51 depletion had significantly greater effects on each of these processes than RET9 depletion in both MTC and PTC cells. Finally, we showed that expression of RET, particularly RET51, was correlated with malignancy in a panel of human thyroid tumour tissues. Together, our data show that RET expression promotes a more mesenchymal phenotype with reduced cell–cell adhesion and increased invasiveness in PTC cell models, but is more important for tumour cell survival, proliferation and anoikis resistance in MTC models. Our data suggest that the RET51 isoform plays a more prominent role in mediating these processes compared to RET9.Keywords
This publication has 55 references indexed in Scilit:
- Distinct Temporal Regulation of RET Isoform Internalization: Roles of Clathrin and AP2Traffic, 2015
- Integrated Genomic Characterization of Papillary Thyroid CarcinomaCell, 2014
- Diffuse Cellular and Fibrosing Interstitial Pneumonitis With Desquamative Interstitial Pneumonitis-like Features Associated With Myeloid NeoplasiaAmerican Journal of Surgical Pathology, 2009
- ZEB1 Enhances Transendothelial Migration and Represses the Epithelial Phenotype of Prostate Cancer CellsMolecular Biology of the Cell, 2009
- The transcription factor ZEB1 (δEF1) represses Plakophilin 3 during human cancer progressionFEBS Letters, 2007
- Correlation Between Genetic Alterations and Microscopic Features, Clinical Manifestations, and Prognostic Characteristics of Thyroid Papillary CarcinomasAmerican Journal of Surgical Pathology, 2006
- Diagnostic Value of Differential Expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in Benign and Malignant Follicular-Derived Lesions of the Thyroid: An Immunohistochemical Tissue Microarray AnalysisEndocrine Pathology, 2006
- Differential requirement of Tyr1062 multidocking site by RET isoforms to promote neural cell scattering and epithelial cell branchingOncogene, 2004
- The GDNF family: Signalling, biological functions and therapeutic valueNature Reviews Neuroscience, 2002
- Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesisGenes & Development, 2001